Rocky Mountain Laboratories

Rocky Mountain Laboratories (RML) is part of the NIH Intramural Research Program and is located in Hamilton, Montana. Operated by the National Institute of Allergy and Infectious Diseases, RML conducts research on maximum containment pathogens such as Ebola as well as research on prions and intracellular pathogens such as Coxiella burnetti and Francisella tularensis.[2][3][4] RML operates one of the few Biosafety level 4 laboratories in the United States, as well as Biosafety level 3 and ABSL3/4 laboratories.[5]

Rocky Mountain Laboratories
Agency overview
Formed1928 (1928)[1]
Preceding agency
  • Hygienic Laboratory
HeadquartersHamilton, Montana
Employees400[1]
Parent agencyNational Institute of Allergy and Infectious Disease, National Institutes of Health, United States Department of Health & Human Services
Website

In February 2020, electron microscope images of SARS-CoV-2 were collected at RML.[6]

References
  1. "Rocky Mountain Laboratories Overview, NIAID, NIH". niaid.nih.gov. Retrieved 2016-10-28.
  2. "Heinz Feldmann, M.D., Ph.D., Laboratory of Virology". niaid.nih.gov. Retrieved 2016-10-28.
  3. "Laboratory of Bacteriology". niaid.nih.gov. Retrieved 2016-10-28.
  4. "Bruce W. Chesebro, M.D., Laboratory of Persistent Viral Diseases, NIAID, NIH". niaid.nih.gov. Retrieved 2016-10-28.
  5. "Rocky Mountain Laboratories". niaid.nih.gov. Retrieved 2016-10-28.
  6. Missoulian. "Hamilton lab releases new images of coronavirus". missoulian.com. Retrieved 2020-02-15.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.